EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase III)Äquivalenzstudie

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B

Adam Cuker, Kaan Kavakli, Laurent Frenzel, Jiaan-Der Wang, Jan Astermark, Monica H Cerqueira, Alfonso Iorio, Olga Katsarou-Fasouli, Robert Klamroth, Amy D Shapiro, Cédric Hermans, Akira Ishiguro und 12 weitere

New England Journal of Medicine · 26.09.2024 · 391 (12) · 1108-1118

DOI: 10.1056/nejmoa2302982 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 26.09.2024. Verfasst von Adam Cuker und 23 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Medicine and of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.C…. Hauptthemen laut MEDLINE: Dependovirus, Factor IX, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusFactor IXGenetic TherapyGenetic VectorsHemophilia BHemorrhageAdolescentAdultAgedHumansMaleMiddle AgedYoung AdultTreatment Outcome

Substanzen

Factor IXfactor IX-Padua

Autor:innen und Institutionen

  • From the Departments of Medicine and of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (A.C.), and Pfizer, Collegeville (J.F., J.R.) - both in Pennsylvania; the…

ORCID-Profile: Margareth C Ozelo

Förderung

  • Pfizer

Zitieren

APA

Cuker, A., Kavakli, K., Frenzel, L., Wang, J. D., Astermark, J., Cerqueira, M. H., Iorio, A., Katsarou-Fasouli, O., Klamroth, R., Shapiro, A. D., Hermans, C., Ishiguro, A., Leavitt, A. D., Oldenburg, J. B., Ozelo, M. C., Teitel, J., Biondo, F., Fang, A., Fuiman, J., …, & BENEGENE-2 Trial Investigators (2024). Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B. New England Journal of Medicine, 391(12), 1108-1118. https://doi.org/10.1056/nejmoa2302982

Vancouver

Cuker A, Kavakli K, Frenzel L, Wang JD, Astermark J, Cerqueira MH, et al. Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B. New England Journal of Medicine. 2024;391(12):1108-1118. doi:10.1056/nejmoa2302982

BibTeX
@article{Cuker2024,
  author = {Cuker, Adam and Kavakli, Kaan and Frenzel, Laurent and Wang, Jiaan-Der and Astermark, Jan and Cerqueira, Monica H and Iorio, Alfonso and Katsarou-Fasouli, Olga and Klamroth, Robert and Shapiro, Amy D and Hermans, Cédric and Ishiguro, Akira and Leavitt, Andrew D and Oldenburg, Johannes B and Ozelo, Margareth C and Teitel, Jerome and Biondo, Francesca and Fang, Annie and Fuiman, Joanne and McKay, John and Sun, Pengling and Rasko, John E J and Rupon, Jeremy and BENEGENE-2 Trial Investigators, BENEGENE-2 Trial Investigators},
  title = {Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {12},
  pages = {1108--1118},
  doi = {10.1056/nejmoa2302982}
}
Kostenlos starten →